ClariVest Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-29,446
Closed -$1.83M – 922
2023
Q4
$1.83M Sell
29,446
-1,418
-5% -$79.3K 0.1% 144
2023
Q3
$1.73M Buy
30,864
+35
+0.1% +$1.97K 0.09% 138
2023
Q2
$1.56M Sell
30,829
-5,101
-14% -$271K 0.08% 167
2023
Q1
$1.96M Buy
35,930
+5
+0% +$292 0.09% 175
2022
Q4
$2.25M Sell
35,925
-123
-0.3% -$8.16K 0.11% 148
2022
Q3
$2.54M Buy
+36,048
New +$2.49M 0.12% 128

Other funds holding AXNX

ClariVest Asset Management's AXNX Position: Q1 2024 in Review

ClariVest Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 29,446 shares — an estimated $1.83M sold.

ClariVest Asset Management first reported a position in AXNX in Q3 2022 and held it in 6 quarters. The position peaked at $2.54M in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • ClariVest Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • ClariVest Asset Management sold 29,446 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $1.83M.
  • ClariVest Asset Management first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • ClariVest Asset Management's Axonics, Inc. Common Stock position peaked at $2.54M in Q3 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on ClariVest Asset Management's 13F filing for Q1 2024, filed 7 May 2024.